NIDDK Scientists Detect New Epitope On HIV-1 Protein Gp41 Using AbD Serotec-generated Recombinant Mini-Antibody
AbD Serotec, a division of MorphoSys AG, announced the publication of a scientific research paper from one of its customers. Scientists working in the team of Drs. Clore and Bewley at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the U.S.
More: continued here
Filed under: HIV / AIDS on January 9th, 2008